Abstract: The present invention is directed to a process for improving daunorubicin and doxorubicin production by means of a recombinant microorganism in which a gene of daunorubicin metabolism is mutated. The mutated gene is preferably dnrU and/or dnrX.
Type:
Grant
Filed:
January 14, 1999
Date of Patent:
April 3, 2001
Assignee:
Pharmacia & Upjohn, S.P.A.
Inventors:
Silvia Filippini, Natalia Lomovskaya, Leonid Fonstein, Anna Luisa Colombo, C. Richard Hutchinson, Sharee L. Otten, Umberto Breme